Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia.

Shastri, Yogesh M

Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. [electronic resource] - International journal of cancer Dec 2006 - 2651-6 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0020-7136

10.1002/ijc.22243 doi


Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--metabolism
Colorectal Neoplasms--diagnosis
Enzyme-Linked Immunosorbent Assay
Feces--enzymology
Female
Humans
Male
Middle Aged
Prospective Studies
Pyruvate Kinase--metabolism
Sensitivity and Specificity